Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) - Share price - Overview

Stock Report

Teva Pharmaceutical Industries Ltd TEVA

Last Price
$21.09

Day Change
-0.14|-0.66%

As of 21/05/2018
16:14:33 EDT | USD
Minimum 15 Minutes Delay.

Last Close21.23
Day Range20.94 - 21.49
Mkt Cap21.41Bil
52-Wk Range10.85 - 33.82
Yield %2.40
ISINUS8816242098
Volume8,677,538
P/E-1.33
P/S0.99
P/CF4.41

Share Price

Financials
201520162017
More ...
Income Statement
Revenue19,652.0021,903.0022,385.00
Operating Income4,483.004,652.003,491.00
Net Income1,588.00329.00-16,265.00
Basic EPS1.840.07-16.26
Avg. Diluted Shares Outstanding8649611,016
Balance Sheet
Current Assets18,398.0016,961.0015,382.00
Non Current Assets35,860.0075,929.0055,233.00
Total Assets54,258.0092,890.0070,615.00
Current Liabilities13,005.0018,519.0017,921.00
Total Liabilities---
Total Equity29,769.0033,337.0017,359.00
Cash Flow
Operating Cash Flow5,542.005,225.003,507.00
Capital Expenditure-772.00-901.00-874.00
Free Cash Flow4,770.004,324.002,633.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

51,800
Key Stats
More ...
Price/Earning TTM-1.34
Price/Book1.45
Price/Sales TTM0.96
Rev Growth (3 year avg)3.36
EPS Growth (3 year avg)-
Operating Margin % TTM15.60
Net Margin % TTM-72.66
ROE TTM-76.07
Debt/Equity2.10
Dividends
PreviousLatest
More ...
Declared Date02/08/1731/10/17
Ex-Div25/08/1727/11/17
Paid14/09/1712/12/17
Amnt0.090.09
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.